2008-03-06 11:53:09 -

www.researchandmarkets.com - Research and Markets (www.researchandmarkets.com/reports/c85046) has announced the addition of "Novavax, Inc.-Detailed Product Pipeline" to their offering.

Pipeline Reports contain detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones.

Scope of the reports

Each

Pipeline Report provides the user with real detail on a company's pipeline.

In addition to business summaries, contact information, company details and selected financial data, each report also contains extensive information in tabular and graphical formats on a company's product pipeline and disease hub classification.

Product details consist of complete descriptions, therapeutic indication, drug class, mechanism of action and clinical trial information. Every report also includes detail on a company's deals and alliances and recent corporate news including key milestones.

Key benefits

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

Keep track of your competitors and partners by better understanding their product pipeline.

Monitor a company's research effectiveness by determining pipeline depth and numbers of products in development by clinical phase.

Topics Covered:

Competitor

Business Summary

Contact Information

Selected Financial Data

Company Details

Product Glance (Table/Graph)

Disease Hub Classification (Table/Graph)

Product Pipeline

Products

Competitor Details by Therapeutic Indication

Recent Updates

Sample Screenshot

For more information, visit www.researchandmarkets.com/reports/c85046

Source: Life Science Analytics

Research and Markets
Laura Wood
Senior Manager
Fax: +353 1 4100 980
press@researchandmarkets.com